← Leaderboards
Maria Carmalita Alexander-Bridges
Massachusetts General Hospital
$2,166,897
Attributed
$2,166,897
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,166,897 · 2
By mechanism
R01$1,995,897 · 1
R21$171,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Ann E Taylor$3,243,924
- Joseph Avruch$32,720,549
- Jeevendra Martyn$10,698,401
- Joseph Vincent Bonventre$46,605,730
- Saumya Das$14,341,004
Others in their field
Top investigators on “Protein Kinase”
- David Heimbrook · Leidos Biomedical Research, Inc.$63,024,346
- Asrar B. Malik · University Of Illinois At Chicago$42,318,340
- John Blenis · Harvard University (Medical School)$31,872,790
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$25,670,024
- Michael H Nathanson · Yale University$25,355,113
- Joel S Greenberger · University Of Pittsburgh At Pittsburgh$24,937,005
Research focus
Protein KinaseMass SpectrometryLaboratory RatDna Binding ProteinInsulinPhosphorylationTranscription FactorGenetic TranscriptionGlucoseHyperinsulinismAdenosine MonophosphateAutoradiographyCaenorhabditis ElegansCaloric Dietary ContentCho CellsEnzyme ActivityGel Mobility Shift AssayLongevityNutrition Related TagPhosphotransferasesPolymerase Chain ReactionProtein SequenceSds Polyacrylamide Gel ElectrophoresisThin Layer Chromatography
Grant awards (7)
Role of AMP kinase and DAF-16 in Mediating the Effect o*$389,116
R01 · FY2005 · AG
Role of AMP kinase and DAF-16 in Mediating the Effect o*$389,116
R01 · FY2004 · AG
Role of AMP kinase and DAF-16 in Mediating the Effect o*$50,317
R01 · FY2004 · AG
Role of AMP kinase and DAF-16 in Mediating the Effect o*$389,116
R01 · FY2003 · AG
Role of AMP kinase and DAF-16 in Mediating the Effect o*$389,116
R01 · FY2002 · AG
AMP kinase and DAF 16--Chloric Restriction of Longevity$389,116
R01 · FY2001 · AG
DAF16 HOMOLOGUES &MEDIATING COMPLICATIONS OF DIABETES$171,000
R21 · FY2000 · DK